Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ ºê·Î¸ðº¥Á¨ ½ÃÀåÀº 2024³â¿¡ 12¾ï ´Þ·¯¸¦ Â÷ÁöÇÏ¸ç ¿¹Ãø ±â°£ Áß CAGRÀº 5.3%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 17¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. ºê·Î¸ðº¥Á¨Àº ÈÇÐ½Ä C6H5Br·Î Ç¥ÇöµÇ´Â À¯±â ÈÇÕ¹°·Î ¸Å¿î ³¿»õ°¡ ³ª´Â ¹«»ö ¾×üÀÔ´Ï´Ù. ¿ë¸Å ¹× À¯±â ÇÕ¼º ½Ã¾àÀ¸·Î »ç¿ëµË´Ï´Ù. ºê·Î¸ðº¥Á¨Àº Ã˸ÅÀÇ Á¸ÀçÇÏ¿¡ º¥Á¨°ú ºê·ÒÀ» ¹ÝÀÀ½ÃÄÑ Á¦Á¶ÇÕ´Ï´Ù. ÀǾàǰ ¹× ³ó¾à ÇÕ¼º µî ´Ù¾çÇÑ ÈÇÐ ¹ÝÀÀ¿¡ »ç¿ëµÇ´Â ´Ù¿ëµµÇÑ ÈÇÕ¹°ÀÔ´Ï´Ù.
¼ºÀåÇÏ´Â Á¦¾à »ê¾÷
ºê·Î¸ðº¥Á¨Àº Ȱ¼º ¼ººÐ ¹× ½Ã¾àÀ» Æ÷ÇÔÇÑ ´Ù¾çÇÑ ÀǾà ÈÇÕ¹°À» ÇÕ¼ºÇÒ ¶§ Áß¿äÇÑ Áß°£Ã¼ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÇ·á ÀÎÇÁ¶óÀÇ È®´ë¿Í ¼¼°è R&D ÅõÀÚ Áõ°¡·Î ÀÎÇØ ºê·Î¸ðº¥Á¨¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ½Å¾à ó¹æ Áõ°¡·Î ÀÎÇØ Á¦¾à ºÎ¹®Àº ƯÈ÷ ¼±Áø±¹°ú ½ÅÈï °æÁ¦±¹¿¡¼ ºê·Î¸ðº¥Á¨ÀÇ ¼Òºñ¸¦ Áö¼ÓÀûÀ¸·Î ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ¿¹Ãø ±â°£ Áß ½ÃÀå ¼ºÀåÀ» À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
´ëü ÈÇй°Áú
µ¿ÀÏÇÑ ¿ëµµÀÇ ´ëü ½Ã¾àÀ̳ª ´ëü ¿ë¸Å´Â ºñ¿ë È¿À²¼º, °¡¿ë¼º, ȯ°æ ģȼº µîÀÇ ÀÌÀ¯·Î ¼±È£µÇ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ÀÌ·¯ÇÑ ´ëü ÈÇй°ÁúÀº ƯÈ÷ ºñ¿ë¿¡ ¹Î°¨ÇÑ ½ÃÀå¿¡¼ »ê¾÷ °øÁ¤¿¡¼ ºê·Î¸ðº¥Á¨¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ³·Ãâ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÈÇй°Áú »ç¿ë¿¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦°¡ ´õ ¾ÈÀüÇÑ ´ëü ¹°Áú·ÎÀÇ ÀüȯÀ» ´õ¿í ÃËÁøÇϰí ÀÖÀ¸¸ç, ƯÁ¤ Áö¿ª¿¡¼´Â ºê·Î¸ðº¥Á¨ ½ÃÀåÀÇ ¼ºÀåÀ» Á¦ÇÑÇϰí ÀÖ½À´Ï´Ù.
Ư¼öÈÇÐÁ¦Ç°ÀÇ È®´ë
ºê·Î¸ðº¥Á¨Àº ÀǾàǰ, »ìÃæÁ¦ ¹× Æú¸®¸Ó¿¡ »ç¿ëµÇ´Â Ư¼ö ÈÇÐ ¹°Áú Á¦Á¶¿¡ ³Î¸® »ç¿ëµË´Ï´Ù. »ê¾÷°è°¡ °í¼º´ÉÀÇ ¸ÂÃãÇü ¼Ö·ç¼ÇÀ» Á¡Á¡ ´õ ¸¹ÀÌ ¿ä±¸ÇÔ¿¡ µû¶ó ºê·Î¸ðº¥Á¨Àº Çõ½ÅÀûÀÎ ÈÇÐ Á¦Á¦¿¡¼ ±× ÀÔÁö¸¦ ´ÙÁö°í ÀÖ½À´Ï´Ù. Ư¼ö ÈÇÐ ºÎ¹®ÀÇ ¼ºÀå, ƯÈ÷ ÷´Ü Á¦Á¶ ¹× R&D¿¡ ÅõÀÚÇÏ´Â Áö¿ª¿¡¼´Â ¿¹Ãø ±â°£ Áß ºê·Î¸ðº¥Á¨¿¡ ´ëÇÑ »ó´çÇÑ ¼ö¿ä°¡ âÃâµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¿øÀç·á ºñ¿ë º¯µ¿
¼ö±Þ ºÒ±ÕÇü, ÁöÁ¤ÇÐÀû ¹®Á¦ ¶Ç´Â ¹«¿ª Á¦ÇÑÀ¸·Î ÀÎÇÑ °¡°Ý º¯µ¿Àº ºê·Î¸ðº¥Á¨ÀÇ »ý»ê°ú ¼öÀͼº¿¡ È¥¶õÀ» ÃÊ·¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÒÈ®½Ç¼ºÀº Á¾Á¾ Á¦Á¶¾÷üÀÇ Àå±â Àü·« ¼ö¸³ ´É·Â¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ´Ù¿î½ºÆ®¸² Á¦Ç°ÀÇ °¡°Ý °áÁ¤·Â¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ¿øÀÚÀç ºñ¿ëÀº Àüü »ý»ê ºñ¿ëÀÇ Áß¿äÇÑ °áÁ¤ ¿äÀÎÀ̱⠶§¹®¿¡ ÀÌ ¿äÀÎÀº ¿©ÀüÈ÷ ½ÃÀå¿¡¼ Áß¿äÇÑ °úÁ¦ÀÔ´Ï´Ù.
COVID-19 ÆÒµ¥¹ÍÀº °ø±Þ¸Á Áß´Ü, »ê¾÷ Ȱµ¿ °¨¼Ò, ³ëµ¿·Â È®º¸ Á¦ÇÑÀ¸·Î ÀÎÇØ ºê·Î¸ðº¥Á¨ ½ÃÀåÀ» È¥¶õ¿¡ ºü¶ß·È½À´Ï´Ù. Àü¿°º´ ´ëÃ¥ÀÌ °ÈµÊ¿¡ µû¶ó Á¦¾à »ê¾÷ ¼ö¿ä´Â ÀÌ·¯ÇÑ °¨¼Ò¸¦ ºÎºÐÀûÀ¸·Î »ó¼âÇß½À´Ï´Ù. ±×·¯³ª ÆÒµ¥¹Í ÀÌÈÄ »ê¾÷ÀÌ È¸º¹µÇ°í »ý»ê ¼öÁØÀÌ Á¤»óÈµÇ¸é¼ Á¦¾à ¹× Ư¼ö ÈÇÐ ºÎ¹® ¼ö¿ä Áõ°¡¿¡ ÈûÀÔ¾î ½ÃÀåÀº ¸ð¸àÅÒÀ» ȸº¹Çϱ⠽ÃÀÛÇß½À´Ï´Ù.
¿¹Ãø ±â°£ Áß Æä´Ò ¸¶±×³×½· ºê·Î¸¶ÀÌµå ºÎ¹®ÀÌ °¡Àå Å« ºÎ¹®À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¿¹Ãø ±â°£ Áß Æä´Ò¸¶±×³×½· ºê·Î¸¶ÀÌµå ºÎ¹®ÀÌ ½ÃÀåÀ» Áö¹èÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¿ìÀ§´Â ÈÇÐ ÇÕ¼º, ƯÈ÷ ÀǾàǰ ¹× Ư¼ö ÈÇÐ ¹°Áú¿¡ ±¤¹üÀ§ÇÏ°Ô »ç¿ëµÇ±â ¶§¹®ÀÔ´Ï´Ù. Çʼö ½Ã¾àÀÎ Æä´Ò¸¶±×³×½· ºê·Î¸¶À̵å´Â °íºÎ°¡°¡Ä¡ ÈÇÕ¹°À» »ý»êÇÏ´Â ±×¸®³Ä¸£ ¹ÝÀÀ¿¡ ³Î¸® »ç¿ëµË´Ï´Ù. º¹ÀâÇÑ À¯±â ÇÕ¼º ¹× °í¼øµµ ½Ã¾à¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡µµ ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.
Á¦¾à µî±Þ ºÎ¹®Àº ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¿¹Ãø ±â°£ Áß ÀǾàǰ Á¦Á¶¿¡¼ °í¼øµµ ÈÇÕ¹°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀǾàǰ µî±Þ ºÎ¹®ÀÌ °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Á¦¾à µî±Þ ºê·Î¸ðº¥Á¨Àº ¿ø·á ÀǾàǰ ÇÕ¼ºÀÇ Áß°£Ã¼·Î ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. Àü ¼¼°è¿¡¼ ÇコÄÉ¾î ¹ßÀü¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í Á¦¾à ºÎ¹®ÀÇ R&D ÅõÀÚ°¡ Áõ°¡ÇÏ¸é¼ ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀǾàǰ Á¦Á¶¿¡ °íǰÁú ¿ø·á¸¦ ¿ä±¸ÇÏ´Â ¾ö°ÝÇÑ ±ÔÁ¦´Â Á¦¾à µî±Þ ºê·Î¸ðº¥Á¨¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù.
¿¹Ãø ±â°£ Áß ºÏ¹Ì°¡ ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ÀÌ Áö¿ªÀÇ Á¦¾à ¹× ÈÇÐ »ê¾÷ÀÌ Àß ¹ß´ÞµÇ¾î ÀÖ°í ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ°¡ Ȱ¹ßÈ÷ ÀÌ·ç¾îÁö°í Àֱ⠶§¹®ÀÔ´Ï´Ù. ÁÖ¿ä Á¦Á¶¾÷üÀÇ Á¸Àç¿Í źźÇÑ ÀÇ·á ÀÎÇÁ¶ó°¡ ºê·Î¸ðº¥Á¨ ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Ã·´Ü ÈÇÐ ¿ëµµ¸¦ Áö¿øÇÏ´Â ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©µµ ºÏ¹Ì ½ÃÀå¿¡¼ÀÇ ¿ìÀ§¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
¿¹Ãø ±â°£ Áß ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀÇ ¿øµ¿·ÂÀº ±Þ¼ÓÇÑ »ê¾÷È, ÀǾàǰ »ý»ê Áõ°¡, Áß±¹ ¹× Àεµ¿Í °°Àº Ư¼ö ÈÇÐÁ¦Ç° ½ÃÀåÀÇ È®´ë¿¡ ±âÀÎÇÕ´Ï´Ù. ºñ¿ë È¿À²ÀûÀÎ ¿ø·áÀÇ °¡¿ë¼º°ú ÷´Ü Á¦Á¶ ´É·Â °³¹ß¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼ ÀÌ Áö¿ªÀÇ ºê·Î¸ðº¥Á¨ ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
According to Stratistics MRC, the Global Bromobenzene Market is accounted for $1.2 billion in 2024 and is expected to reach $1.7 billion by 2030 growing at a CAGR of 5.3% during the forecast period. Bromobenzene is an organic compound with the chemical formula C6H5Br. It's a colorless liquid with a pungent odor. It's used as a solvent and a reagent in organic synthesis. Bromobenzene is produced by reacting benzene with bromine in the presence of a catalyst. It's a versatile compound used in various chemical reactions, including the synthesis of pharmaceuticals and agrochemicals.
Growing pharmaceutical industry
Bromobenzene serves as a critical intermediate in synthesizing various pharmaceutical compounds, including active ingredients and reagents. The expansion of healthcare infrastructure and increased R&D investment globally has escalated the demand for bromobenzene. With rising incidences of chronic diseases and the push for new drug formulations, the pharmaceutical sector continuously fuels the consumption of bromobenzene, especially in developed and emerging economies. This trend is expected to sustain market growth during the forecast period.
Substitute chemicals
Alternative reagents and solvents with similar applications are often preferred due to cost efficiency, availability, or environmental concerns. These substitutes can reduce dependency on bromobenzene in industrial processes, especially in cost-sensitive markets. Additionally, stringent regulations on chemical usage further encourage the shift towards safer alternatives, thereby limiting bromobenzene's market growth in certain regions.
Expanding of specialty chemicals
Bromobenzene is widely used in producing specialty chemicals for applications in pharmaceuticals, agrochemicals, and polymers. As industries increasingly require high-performance and tailored solutions, bromobenzene finds its place in innovative chemical formulations. Growth in the specialty chemicals sector, especially in regions investing in advanced manufacturing and R&D, is expected to create substantial demand for bromobenzene during the forecast period.
Cost fluctuation of raw materials
Price volatility due to supply-demand imbalances, geopolitical issues, or trade restrictions can disrupt the production and profitability of bromobenzene. This uncertainty often impacts manufacturers' ability to plan long-term strategies and affects the pricing dynamics of downstream products. As raw material costs are a significant determinant of overall production costs, this factor remains a critical challenge for the market.
The Covid-19 pandemic disrupted the bromobenzene market due to supply chain interruptions, reduced industrial activities, and limitations in workforce availability. The pharmaceutical industry's demand partially offset this decline as efforts to combat the pandemic intensified. However, as industries recovered post-pandemic and production levels normalized, the market began to regain momentum, driven by increasing demand from pharmaceuticals and specialty chemicals sectors.
The phenylmagnesium bromide segment is expected to be the largest during the forecast period
Over the forecasted timeframe, the phenylmagnesium bromide segment is anticipated to dominate the market. This dominance is attributed to its extensive applications in chemical synthesis, particularly in pharmaceuticals and specialty chemicals. Phenylmagnesium bromide, an essential reagent, is widely used in Grignard reactions for producing high-value compounds. The growing demand for complex organic synthesis and high-purity reagents further supports this segment's prominence.
The pharmaceutical grade segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the pharmaceutical grade segment is predicted to witness the highest growth rate due to the increasing demand for high-purity compounds in drug manufacturing. Pharmaceutical-grade bromobenzene is extensively utilized as an intermediate in synthesizing active pharmaceutical ingredients. The global emphasis on healthcare advancements, coupled with rising R&D investments in the pharmaceutical sector, drives this segment's growth. Additionally, stringent regulations necessitating high-quality inputs in drug production further enhance the demand for pharmaceutical-grade bromobenzene.
During the estimation period, the North America region is anticipated to dominate the market. This is due to the region's well-established pharmaceutical and chemical industries, coupled with significant investments in R&D. The presence of key manufacturers and a robust healthcare infrastructure further drive bromobenzene demand. Additionally, regulatory frameworks supporting advanced chemical applications contribute to the market's dominance in North America.
During the forecast period, the Asia Pacific region is anticipated to register the highest CAGR. This growth is driven by rapid industrialization, increasing pharmaceutical production, and expanding specialty chemical markets in countries like China and India. The availability of cost-effective raw materials and a growing emphasis on developing advanced manufacturing capabilities further boost bromobenzene's demand in the region.
Key players in the market
Some of the key players in Bromobenzene Market include Hawks Chemical Co Ltd, Alfa Aesar, Merck KGaA, ExxonMobil Corporation, Sontara Organo Industries, Tokyo Chemical Industry Co., Ltd., Weifang Yonhop Chemical Co., Ltd., Shandong Henglian Chemical Co., Ltd., Heranba Industries Ltd., Shanghai Wescco Chemical Co., Ltd., ChemSampCo Inc., Aarti Industries Limited, Solvay S.A., Jiangsu Tianxin Chemical Co., Ltd., Arkema Group, Eastman Chemical Company, and Lanxess AG.
In October 2024, Merck, a leading science and technology company, announced a € 70 million expansion of its ADC manufacturing capabilities and capacity at its Bioconjugation Center of Excellence facility in St. Louis, Missouri, USA. This investment will triple existing capacity and enhance the company's contract development and manufacturing organization (CDMO) offering, reinforcing its commitment to clients and patients.
In May 2024, Arkema has agreed to acquire Dow's flexible packaging laminating adhesives business, one of the leading producers of adhesives for the flexible packaging market, generating annual sales of around US$250 million. The proposed acquisition will significantly expand Arkema's portfolio of solutions for flexible packaging, enabling the Group to become a key player in this attractive market.